Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
Paris, A., Gonnet, N., Chaussard, C., Belon, P., Rocourt, F., Saragaglia, D., and Cracowski, J. L. Effect of homeopathy on analgesic intake following knee ligament reconstruction: a phase III monocentre randomized placebo controlled study. Br J Clin Pharmacol 2008;65(2):180-187.
Panossian, A. G., Oganessian, A. S., Ambartsumian, M., Gabrielian, E. S., Wagner, H., and Wikman, G. Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine. 1999;6(1):17-26.
Panossian, A., Gabrielian, E., and Wagner, H. On the mechanism of action of plant adaptogens with particular reference to cucurbitacin R diglucoside. Phytomedicine. 1999;6(3):147-155.
Ukiya, M., Akihisa, T., Yasukawa, K., Tokuda, H., Toriumi, M., Koike, K., Kimura, Y., Nikaido, T., Aoi, W., Nishino, H., and Takido, M. Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica. J.Nat.Prod. 2002;65(2):179-183.
Varshney, J. P. and Naresh, R. Evaluation of a homeopathic complex in the clinical management of udder diseases of riverine buffaloes. Homeopathy 2004;93(1):17-20.
Munoz, S. M., Salvarelli, S. M., Saiz, M. I., and Conde, F. P. A toxic protein from Bryonia dioica Jacq. fruits: the brydiofin. Biochem Biophys Res Commun 3-31-1992;183(3):1011-1018.
Varshney, J. P. and Naresh, R. Comparative efficacy of homeopathic and allopathic systems of medicine in the management of clinical mastitis of Indian dairy cows. Homeopathy 2005;94(2):81-85.
Merck, C. C., Sonnenwald, B., and Rollwage, H. [The administration of homeopathic drugs for the treatment of acute mastitis in cattle]. Berl Munch.Tierarztl.Wochenschr. 8-1-1989;102(8):266-272.
Panosian, A. G. [Effect of Bryonia cucurbitacins on the biosynthesis of eicosanoids in human leukocytes]. Bioorg.Khim. 1985;11(2):264-269.
Panosian, A. G., Dadaian, M. A., and Gabrielian, E. S. [Cucurbitacin R glycoside--a regulator of steroidogenesis and of the formation of prostaglandin E2--a specific modulator of the hypothalamus-hypophysis-adrenal cortex system]. Biull.Eksp.Biol.Med. 1987;104(10):456-457.
Whur, P. White bryony poisoning in a dog. Vet.Rec. 10-18-1986;119(16):411.
Suganda, A. G., Amoros, M., Girre, L., and Fauconnier, B. [Inhibitory effects of some crude and semi-purified extracts of indigenous French plants on the multiplication of human herpesvirus 1 and poliovirus 2 in cell culture]. J Nat Prod 1983;46(5):626-632.
Vartanian, G. S., Parsadanian, G. K., and Karagezian, K. G. [Effect of trihydroxyoctadecadiene acids from Bryonia alba L. on the activity of glycogen metabolism enzymes in alloxan diabetes]. Biull.Eksp.Biol.Med. 1984;97(3):295-297.
Panossian, A. G., Avetissian, G. M., Mnatsakanian, V. A., Batrakov, S. G., Vartanian, S. A., Gabrielian, E. S., and Amroyan, E. A. Unsaturated polyhydroxy acids having prostaglandin-like activity from Bryonia alba II. Major components. Planta Med. 1983;47(1):17-25.
Vartanian, G. S. and Karagezian, K. G. [Normalizing effect of Bryonia alba L. on blood phospholipids in alloxan diabetes]. Vopr.Med.Khim. 1981;27(2):179-181.
Karagezian, K. G., Vartanian, G. S., and Panosian, A. G. [Effect of an extract from the roots of bryony (Bryonia alba) on lipid peroxidation in the liver of rats with alloxan diabetes]. Biull.Eksp.Biol.Med. 1981;92(8):35-37.
Siegall, C. B., Gawlak, S. L., Chace, D., Wolff, E. A., Mixan, B., and Marquardt, H. Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates. Bioconjug.Chem. 1994;5(5):423-429.
Wachinger, M., Samtleben, R., Gerhauser, C., Wagner, H., and Erfle, V. Bryodin, a single-chain ribosome-inactivating protein, selectively inhibits the growth of HIV-1-infected cells and reduces HIV-1 production. Res.Exp.Med.(Berl) 1993;193(1):1-12.
Gawlak, S. L., Neubauer, M., Klei, H. E., Chang, C. Y., Einspahr, H. M., and Siegall, C. B. Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica. Biochemistry 3-18-1997;36(11):3095-3103.
Francisco, J. A., Gawlak, S. L., Miller, M., Bathe, J., Russell, D., Chace, D., Mixan, B., Zhao, L., Fell, H. P., and Siegall, C. B. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture. Bioconjug.Chem. 1997;8(5):708-713.
Karageuzyan, K. G., Vartanyan, G. S., Agadjanov, M. I., Panossian, A. G., and Hoult, J. R. Restoration of the disordered glucose-fatty acid cycle in alloxan-diabetic rats by trihydroxyoctadecadienoic acids from Bryonia alba, a native Armenian medicinal plant. Planta Med. 1998;64(5):417-422.